175 related articles for article (PubMed ID: 35443192)
1. ZYKR1, a novel, potent, and peripherally selective kappa opioid receptor agonist reduces visceral pain and pruritus in animal models.
Jain MR; Patel RB; Prajapati KD; Vyas P; Bandyopadhyay D; Prajapati V; Bahekar R; Patel PN; Kawade HM; Kokare DM; Pawar V; Desai R
Eur J Pharmacol; 2022 Jun; 924():174961. PubMed ID: 35443192
[TBL] [Abstract][Full Text] [Related]
2. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
3. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive and Antipruritic Effects of HSK21542, a Peripherally-Restricted Kappa Opioid Receptor Agonist, in Animal Models of Pain and Itch.
Wang X; Gou X; Yu X; Bai D; Tan B; Cao P; Qian M; Zheng X; Wang H; Tang P; Zhang C; Ye F; Ni J
Front Pharmacol; 2021; 12():773204. PubMed ID: 34867403
[TBL] [Abstract][Full Text] [Related]
5. OCP002, a Mixed Agonist of Opioid and Cannabinoid Receptors, Produces Potent Antinociception With Minimized Side Effects.
Xu B; Zhang Q; Chen D; Zhang M; Zhang R; Zhao W; Qiu Y; Xu K; Xiao J; Niu J; Shi Y; Li N; Fang Q
Anesth Analg; 2023 Feb; 136(2):373-386. PubMed ID: 36638515
[TBL] [Abstract][Full Text] [Related]
6. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
Schattauer SS; Kuhar JR; Song A; Chavkin C
Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
[TBL] [Abstract][Full Text] [Related]
7. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors.
Eans SO; Ganno ML; Mizrachi E; Houghten RA; Dooley CT; McLaughlin JP; Nefzi A
J Med Chem; 2015 Jun; 58(12):4905-17. PubMed ID: 25996309
[TBL] [Abstract][Full Text] [Related]
8. Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.
Vanderah TW; Largent-Milnes T; Lai J; Porreca F; Houghten RA; Menzaghi F; Wisniewski K; Stalewski J; Sueiras-Diaz J; Galyean R; Schteingart C; Junien JL; Trojnar J; Rivière PJ
Eur J Pharmacol; 2008 Mar; 583(1):62-72. PubMed ID: 18282565
[TBL] [Abstract][Full Text] [Related]
9. FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): A peripheral efficacious kappa opioid agonist with unprecedented selectivity.
Vanderah TW; Schteingart CD; Trojnar J; Junien JL; Lai J; Riviere PJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):326-33. PubMed ID: 14993260
[TBL] [Abstract][Full Text] [Related]
10. Estimation of ZYKR1 in human urine and plasma utilizing LC-MS/MS positive electrospray ionization; a kappa opioid receptor (KOR) agonist.
Ghoghari A; Bhatt C; Patel K; Jha A; Patel H; Jain M; Momin T; Parmar D; Patel P
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122982. PubMed ID: 34731743
[TBL] [Abstract][Full Text] [Related]
11. The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via μ- and κ-opioid receptors.
Xu B; Zhang M; Shi X; Zhang R; Chen D; Chen Y; Wang Z; Qiu Y; Zhang T; Xu K; Zhang X; Liedtke W; Wang R; Fang Q
Br J Pharmacol; 2020 Jan; 177(1):93-109. PubMed ID: 31444977
[TBL] [Abstract][Full Text] [Related]
12. Biased Opioid Ligands.
Faouzi A; Varga BR; Majumdar S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
[TBL] [Abstract][Full Text] [Related]
13. The Pharmacological Heterogeneity of Nepenthone Analogs in Conferring Highly Selective and Potent κ-Opioid Agonistic Activities.
Li W; Long JD; Qian YY; Long Y; Xu XJ; Wang YJ; Shen Q; Wang ZN; Yang XC; Xiao L; Sun HP; Xu YL; Chen YY; Xie Q; Wang YH; Shao LM; Liu JG; Qiu ZB; Fu W
ACS Chem Neurosci; 2017 Apr; 8(4):766-776. PubMed ID: 28033462
[TBL] [Abstract][Full Text] [Related]
14. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
[TBL] [Abstract][Full Text] [Related]
15. Involvement of kappa-opioid receptors in visceral nociception in mice.
Larsson MH; Bayati A; Lindström E; Larsson H
Neurogastroenterol Motil; 2008 Oct; 20(10):1157-64. PubMed ID: 18643891
[TBL] [Abstract][Full Text] [Related]
16. Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation.
Zhang LS; Wang J; Chen JC; Tao YM; Wang YH; Xu XJ; Chen J; Xu YG; Xi T; Hu XW; Wang YJ; Liu JG
Acta Pharmacol Sin; 2015 May; 36(5):565-71. PubMed ID: 25816912
[TBL] [Abstract][Full Text] [Related]
17. GR94839, a kappa-opioid agonist with limited access to the central nervous system, has antinociceptive activity.
Rogers H; Birch PJ; Harrison SM; Palmer E; Manchee GR; Judd DB; Naylor A; Scopes DI; Hayes AG
Br J Pharmacol; 1992 Aug; 106(4):783-9. PubMed ID: 1327387
[TBL] [Abstract][Full Text] [Related]
18. Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities.
Schmidhammer H; Erli F; Guerrieri E; Spetea M
Molecules; 2020 Nov; 25(21):. PubMed ID: 33147885
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.
Kaski SW; White AN; Gross JD; Trexler KR; Wix K; Harland AA; Prisinzano TE; Aubé J; Kinsey SG; Kenakin T; Siderovski DP; Setola V
J Pharmacol Exp Ther; 2019 Nov; 371(2):487-499. PubMed ID: 31492823
[TBL] [Abstract][Full Text] [Related]
20. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
Linz K; Christoph T; Tzschentke TM; Koch T; Schiene K; Gautrois M; Schröder W; Kögel BY; Beier H; Englberger W; Schunk S; De Vry J; Jahnel U; Frosch S
J Pharmacol Exp Ther; 2014 Jun; 349(3):535-48. PubMed ID: 24713140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
